CNE100001500
CNE100001500
JINCHENG PHARM
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 2.736.927.223 | 3.373.387.401 | 18.9% |
| Cost of Revenue | 1.750.628.415 | 2.019.599.405 | 13.3% |
| Gross Profit | 986.298.808 | 1.353.787.996 | 27.1% |
| 849.670.397 | 1.056.187.432 | 19.6% | |
| Operating Income | 136.628.411 | 297.600.563 | 54.1% |
| Pretax Income | 78.021.221 | 268.448.023 | 70.9% |
| Net Income Common Stockholders | 44.186.260 | 196.780.752 | 77.5% |
| -- | -- | -- | |
| -- | -- | -- |